PITTSBURGH — Generic drug maker Mylan's board of directors has approved a new management structure for the company, effective Jan. 1, 2012.
Mylan's board approved the transition of current chairman and CEO Robert Coury to the new role of executive board chairman. With this, Mylan president Heather Bresch will become CEO and directly report to the company's board.